Resident
Department of Neurological Surgery, Columbia University Irving Medical Center
New York, New York, United States
Michael G Argenziano BA is a fourth year medical student at Columbia University Vagelos College of Physicians and Surgeons (VP&S), graduating this May with an MD and a Masters of Science (MS) in cancer bioinformatics, and is currently in the 2023 Neurological Surgery Residency Match. Michael grew up in New Jersey, and completed his undergraduate degree at Columbia College, where he graduated summa cum laude and majored in biophysics while working in a Systems Biology/Cancer Genetics laboratory focused on devising new computationally-driven precision medicine approaches to predicting therapeutic targets. In medical school at Columbia VP&S, Michael joined a translational brain tumor laboratory led by Dr. Jeffrey N Bruce and Dr. Peter Canoll, where he was awarded both an NIH T35 training grant as well as a Columbia University Dean's Research Fellowship, both aimed at understanding patient-specific responses to a variety of targeted chemotherapies and immunotherapies in glioma. Michael has co-authored several publications in glioma, including most recently as a co-first author of a clinical trial for Convection-Enhanced Delivery (CED) of topotecan for patients with recurrent glioblastoma, published in Lancet Oncology.
Disclosure information not submitted.
Local Delivery of Topotecan Induces Immunogenic Cell Death and Associated Myeloid Response in GBM
Saturday, May 4, 2024
2:15 PM – 2:17 PM CT
Saturday, May 4, 2024
2:09 PM – 2:13 PM CT